30+ Years
Self-relied Itellectual Property
30+ In Vaccine Research
400+ Research Staff
5 Production Base
International Cooperation
Development History
Production base
In vaccine research
Research staff
Available vaccine varieties
Shenzhen starts offering Kangtai COVID booster shots
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
BioKangtai's Inactivated COVID-19 Vaccine (Vero Cell) is Approved Homologous Booster Vaccination in China
BioKangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Was Approved As Booster Dose in Indonesia
BioKangtai 30 Million Doses of Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported